Search research articles
Contact Us
Filters
Showing results (31-40 of 188) with videos related to
Page
of 19
Sort By:
Molecules (Basel, Switzerland)
|
January 11, 2018
Iridoids and Other Monoterpenes in the Alzheimer's Brain: Recent Development and Future Prospects
Solomon Habtemariam
Evidence-Based Complementary and Alternative Medicine : Ecam
|
March 8, 2018
Could We Really Use <i>Aloe vera</i> Food Supplements to Treat Diabetes? Quality Control Issues
Solomon Habtemariam
Toxicon : Official Journal of the International Society on Toxinology
|
October 17, 2001
Hamamelitannin from Hamamelis virginiana inhibits the tumour necrosis factor-alpha (TNF)-induced endothelial cell death in vitro
Solomon Habtemariam
Pharmaceutical Biology
|
September 18, 2012
The anti-obesity potential of sigmoidin A
Solomon Habtemariam
Biomedicines
|
June 27, 2024
Anti-Inflammatory Therapeutic Mechanisms of Isothiocyanates: Insights from Sulforaphane
Solomon Habtemariam
Molecules (Basel, Switzerland)
|
May 13, 2026
Natural Products as a Pipeline for Next-Generation Neurodegenerative Drugs: From Single-Target Failure to Multi-Target Opportunity in Alzheimer's and Parkinson's Disease
Solomon Habtemariam
Planta Medica
|
November 27, 2009
Comparative antioxidant, prooxidant and cytotoxic activity of sigmoidin A and eriodictyol
Solomon Habtemariam, Ermias Dagne
Biomedicines
|
March 29, 2018
Plant-Derived Anticancer Agents: Lessons from the Pharmacology of Geniposide and Its Aglycone, Genipin
Solomon Habtemariam, Giovanni Lentini
Mini Reviews in Medicinal Chemistry
|
January 25, 2017
Natural Therapies of the Inflammatory Bowel Disease: The Case of Rutin and its Aglycone, Quercetin
Solomon Habtemariam, Abebech Belai
Mini Reviews in Medicinal Chemistry
|
May 3, 2015
The therapeutic potential of rutin for diabetes: an update
Solomon Habtemariam, Giovanni Lentini
Page
of 19
Search research articles
Search
Showing results (31-40 of 188) with videos related to
Sort By:
Page
of 19
Molecules (Basel, Switzerland)
|
January 11, 2018
Iridoids and Other Monoterpenes in the Alzheimer's Brain: Recent Development and Future Prospects
Solomon Habtemariam
Evidence-Based Complementary and Alternative Medicine : Ecam
|
March 8, 2018
Could We Really Use <i>Aloe vera</i> Food Supplements to Treat Diabetes? Quality Control Issues
Solomon Habtemariam
Toxicon : Official Journal of the International Society on Toxinology
|
October 17, 2001
Hamamelitannin from Hamamelis virginiana inhibits the tumour necrosis factor-alpha (TNF)-induced endothelial cell death in vitro
Solomon Habtemariam
Pharmaceutical Biology
|
September 18, 2012
The anti-obesity potential of sigmoidin A
Solomon Habtemariam
Biomedicines
|
June 27, 2024
Anti-Inflammatory Therapeutic Mechanisms of Isothiocyanates: Insights from Sulforaphane
Solomon Habtemariam
Molecules (Basel, Switzerland)
|
May 13, 2026
Natural Products as a Pipeline for Next-Generation Neurodegenerative Drugs: From Single-Target Failure to Multi-Target Opportunity in Alzheimer's and Parkinson's Disease
Solomon Habtemariam
Planta Medica
|
November 27, 2009
Comparative antioxidant, prooxidant and cytotoxic activity of sigmoidin A and eriodictyol
Solomon Habtemariam, Ermias Dagne
Biomedicines
|
March 29, 2018
Plant-Derived Anticancer Agents: Lessons from the Pharmacology of Geniposide and Its Aglycone, Genipin
Solomon Habtemariam, Giovanni Lentini
Mini Reviews in Medicinal Chemistry
|
January 25, 2017
Natural Therapies of the Inflammatory Bowel Disease: The Case of Rutin and its Aglycone, Quercetin
Solomon Habtemariam, Abebech Belai
Mini Reviews in Medicinal Chemistry
|
May 3, 2015
The therapeutic potential of rutin for diabetes: an update
Solomon Habtemariam, Giovanni Lentini
Page
of 19